Firebrick Pharma Limited (AU:FRE) has released an update.
Firebrick Pharma Limited has fully complied with the recommendations of the ASX Corporate Governance Council, as detailed in their Corporate Governance Statement for the financial year ending 30 June 2024. The complete statement, which outlines the roles and responsibilities of the board and management, is available on the company’s website. This adherence to governance principles highlights Firebrick Pharma’s commitment to transparency and solid management foundations.
For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.
